Common PTSD Drug Doesn’t Really Help Carlat Reports

Common PTSD Drug Doesn’t Really Help

The Carlat Psychiatry Report, Volume 5, Number 2, February 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n2/

From The Carlat Psychiatry Report, February 2007, Understanding Psychiatric Research

Issue Links: Learning Objectives | Editorial Information

Topics: PTSD

Ivan Oransky, MD

Guanfacine is an alpha-2 agonists approved for the treatment of hypertension, but commonly prescribed for posttraumatic stress disorder. Like clonidine, another alpha-2 agonist, guanfacine is believed to decrease norepinephrine release from noradrenergic neurons during states of heightened arousal.

You can't view details of this content, please login or buy subscription here

Ivan Oransky, MD

Deputy Editor, The Scientist magazine, Statistics columnist for CNS News Clinical Assistant Professor of Medicine, New York University

Dr. Oransky has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.